Last reviewed · How we verify
NCT06937697
Clinical of Hypersensitivity Reduction Efficacy on Two Toothpastes
Phase 3 trial testing Test toothpaste in Hypersensitivity in 87 participants. Completed in 13 December 2024.
13 December 2024
Quick facts
| Lead sponsor | Colgate Palmolive |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 87 |
| Start date | 8 October 2024 |
| Primary completion | 13 December 2024 |
| Estimated completion | 13 December 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Test toothpaste — full drug profile →
- Control toothpaste — full drug profile →
Conditions studied
- Hypersensitivity — all drugs for Hypersensitivity →
Sponsor
Colgate Palmolive — full company profile →
Who can join
Adults 18 to 70, any sex, with Hypersensitivity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the clinical efficacy of a Dual Zinc Toothpast containing 5% small particle size silica (AC43) as compared to Colgate MaxFresh Tea Toothpaste on dentin hypersensitivity reduction after brushing two times daily (morning and evening) for a period of 8 weeks
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06937697
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Test toothpaste
Trials testing the same drug.
- NCT07352956 — A Clinical Study to Evaluate the Effectiveness of an Test Toothpaste for the Relief of Dentin Hypersensitivity in a Chin · NA · completed
- NCT07419763 — Intra Oral Appliance (IOA) Model Evaluating the Efficacy of Sensitive Toothpaste · NA · completed
- NCT06602466 — A Clinical Study Investigating the Effect of an Experimental Toothpaste Containing Stannous Fluoride in Improving Gingiv · NA · completed
Other recruiting trials for Hypersensitivity
Currently open trials in the same condition.
- NCT07352813 — Intraosseous vs Infiltration Anesthesia in Molar-Incisor Hypomineralization (MIH) Children · NA · recruiting
- NCT06463938 — A Clinical Trial to Compare Lasotronix Alone or in Combination With CPP-ACP to Treat DH · NA · recruiting
- NCT00001406 — Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia · recruiting
Other Colgate Palmolive trials
Trials by the same sponsor.
- NCT07398846 — Efficacy of a Stannous Fluoride Toothpaste, Cetylpyridinium Chloride Mouthwash, and Battery Toothbrush Regimen in Reduci · Phase 3 · recruiting
- NCT07276672 — Efficacy of a Toothpaste Containing Hydrogen Peroxide as Compared to a Regular Fluoride Toothpaste Without Hydrogen Pero · Phase 3 · completed
- NCT07225478 — Clinical Study to Evaluate the Tooth Whitening Efficacy of a New NextGen In-office Whitening System · Phase 3 · completed
- NCT07224828 — The Efficacy of a Battery Toothbrush in the Reduction of Established Plaque and Gingivitis · Phase 3 · completed
- NCT07134231 — Clinical Study to Evaluate the Anti-cavity Efficacy of Three Dentifrices: An In Situ Model · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06937697 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Colgate Palmolive
- Last refreshed: 22 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06937697.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing